Skip to main content
. 2014 Sep 20;8(9):HC01–HC04. doi: 10.7860/JCDR/2014/9092.4878

[Table/Fig-3]:

Improvement seen with severity of lesions as parameter

Improvement seen with severity of lesions as parameter
At 1st follow-up No.of cases (%) At 2nd follow-up No.of cases (%)
Oral Ivermectin single dose 200μg/kg body wt. 32 (53.34%) 16 (26.60%)
Topical Permethrin 5% cream single application 43 (71.66%) 10 (16.66%)
Topical GBHC 1% lotion single application 28 (46.66%) 15 (25.00%)
Topical BB 25% lotion single application 29 (48.33%) 10 (16.66%)